MRC1 and neoplasm: Updated ESMO PMWG guidance recommends inclusion of hypermutated samples for germline focused analysis on tumor CGP given the overall GCR of >5% was maintained for most CSGs in these samples with a disproportionate fraction of true germline variants identified in MMR genes, as expected27.